Deferoxamine Mesylate 60505-6236-06
- Manufacturer
- Apotex Corp.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 5, 2021
- Listing Expires
- December 31, 2027
- Application
- ANDA207384
Need to source Deferoxamine Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferoxamine Mesylate | 500 mg/1 |
Drug Class
Iron Chelating Activity [MoA]Iron Chelator [EPC]
Selected Package
60505-6236-06Selected4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6236-6)